← FDA DRUG APPROVALS

FDA ANDA · ANDA065313

CEFOXITIN

Sponsor: HOSPIRA INC

APPLICATION
ANDA065313
TYPE
ANDA
ORIGINAL APPROVAL
2006-01-23
LATEST ACTION
2014-04-22
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

CEFOXITINDiscontinued
CEFOXITIN SODIUM EQ 1GM BASE/VIAL · INJECTABLE · INJECTION
CEFOXITINDiscontinued
CEFOXITIN SODIUM EQ 2GM BASE/VIAL · INJECTABLE · INJECTION

Approval history

2014-04-22Labeling · Supplement 10 · standardAP
2008-03-05Labeling · Supplement 5AP
2006-01-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →